Overexpression of polo-like kinase 1 is a common and early event in pancreatic cancer

Pancreatology

Volumn 5, Issue 2-3, 2005, Pages 259-265

  Weichert, Wilko ^a   Schmidt, Mathias ^b   Jacob, Juliane ^a   Gekeler, Volker ^b   Langrehr, Jan ^a   Neuhaus, Peter ^a   Bahra, Marcus ^a   Denkert, Carsten ^a   Dietel, Manfred ^a   Kristiansen, Glen ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

Immunohistochemistry; Pancreatic carcinoma; Pancreatic intraepithelial neoplasia; Polo like kinase; Prognosis

Indexed keywords

POLO LIKE KINASE 1;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 19944376878     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000085280     Document Type: Article

References (26)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer Society: Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
2. Haller DG: New perspectives in the management of pancreas cancer. Semin Oncol 2003; 30:3-10.
3. Sunkel CE, Glover DM: Polo, a mitotic mutant of Drosophila displaying abnormal spindle poles. J Cell Sci 1988;89:25-38.
4. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S: The protein kinase complement of the human genome. Science 2002;298: 1912-1934.
5. Nigg EA: Polo-like kinases: Positive regulators of cell division from start to finish. Curr Opin Cell Biol 1998;10:776-783.
6. Donaldson MM, Tavares AA, Hagan IM, Nigg EA, Glover DM: The mitotic roles of Polo-like kinase. J Cell Sci 2001;114:2357-2358.
7. Liu X, Erikson RL: Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 2003;100:5789-5794.
8. Spänkuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K: Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. J Natl Cancer Inst 2002;94:1863-1877.
9. Elez R, Piiper A, Kronenberger B, Kock M, Brendel M, Hermann E, Pliquett U, Neumann E, Zeuzem S: Tumor regression by combination antisense therapy against Plk1 and Bcl-2. Oncogene 2003;22:69-80.
10. Tokumitsu Y, Mori M, Tanaka S, Akazawa K, Nakano S, Niho Y: Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol 1999;15:687-692.
11. Weichert W, Denkert C, Schmidt M, Gekeler V, Wolf G, Kobel M, Dietel M, Hauptmann S: Polo like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer 2004;90:815-821.
12. Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K: Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 1999;59:2794-2797.
13. Kneisel L, Strebhardt K, Bernd A, Wolter M, Binder A, Kaufmann R: Expression of polo-like kinase (PLK1) in thin melanomas: A novel marker of metastatic disease. J Cutan Pathol 2002;29:354-358.
14. Wolf G, Elez R, Doermer A, Holtrich U, Ackermann H, Stutte HJ, Altmannsberger HM, Rubsamen-Waigmann H, Strebhardt K: Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer. Oncogene 1997;14:543-549.
15. Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, Loening K, Dietel M, Kristiansen G: Polo like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 2004;60:240-245.
16. Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, Kimura M, Okano Y, Saji S: Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci 2003; 94:148-152.
17. Ito Y, Miyoshi E, Sasaki N, Kakudo K, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K, Miyauchi A: Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. Br J Cancer 2004; 90:414-418.
18. Dietzmann K, Kirches E, von Bossanyi, Jachau K, Mawrin C: Increased human polo-like kinase-1 expression in gliomas. J Neurooncol 2001;53:1-11.
19. Toyoshima-Morimoto F, Taniguchi E, Nishida E: Plk1 promotes nuclear translocation of human Cdc25C during prophase. EMBO Rep 2002;3:341-348.
20. Yuan J, Eckerdt F, Bereiter-Hahn J, Kurunci-Csacsko E, Kaufmann M, Strebhardt K: Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1. Oncogene 2002;21: 8282-8292.
21. Sumara I, Vorlaufer E, Stukenberg PT, Kelm O, Redemann N, Nigg EA, Peters JM: The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. Mol Cell 2002;9:515-525.
22. Barr FA, Sillje HH, Nigg EA: Polo-like kinases and the orchestration of cell division. Nat Rev Mol Cell Biol 2004;5:429-440.
23. Golan A, Yudkovsky Y, Hershko A: The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk. J Biol Chem 2002;277: 15552-15557.
24. Feng Y, Hodge DR, Palmieri G, Chase DL, Longo DL, Ferris DK: Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex. Biochem J 1999;339:435-442.
25. Gray PJ Jr, Bearss DJ, Han H, Nagle R, Tsao MS, Dean N, Von Hoff DD: Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol Cancer Ther 2004;3:641-646.
26. Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, Meltzer PS, Ried T: Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 1999;154: 525-536.